<unk>  is an adenosine nucleotide prodrug that is FDA authorized for the treatment of suspected or laboratory confirmed SARS-CoV-2 infection in adults and pediatric patients hospitalized with severe disease under an Emergency Use Authorization (EUA).   Common adverse reactions include nausea, constipation, pyrexia, acute respiratory failure, anemia (decreased hemoglobin), acute kidney injury (decreased eGFR, decreased creatinine clearance, or increased creatinine), hyperglycemia (increased blood glucose), and increased transaminases.
Remdesivir
Fomivirsen
Entecavir
Saquinavir
Letermovir
Fosamprenavir
Abacavir
Adefovir